What is the recommended management for a patient with retrosternal and epigastric burning sensations and a normal endoscopy showing no severe gastritis or gastroesophageal reflux disease (GERD) changes?

Management of Retrosternal and Epigastric Burning with Normal Endoscopy

Initiate empirical therapy with a standard once-daily proton pump inhibitor (PPI) for 4-8 weeks, as this patient likely has non-erosive reflux disease (NERD) or functional heartburn, both of which respond to acid suppression despite normal endoscopic findings. 1

Initial Treatment Approach

• Start with once-daily PPI therapy at standard dosing (e.g., omeprazole 20 mg) for 4-8 weeks, as PPIs are more effective than H2-receptor antagonists, which are more effective than placebo for symptomatic esophageal syndromes without esophagitis 1

• Assess response at 4-8 weeks: If symptoms resolve, wean to the lowest effective dose or convert to on-demand therapy 1

• Target lifestyle modifications based on specific symptom triggers: weight loss if overweight/obese, head-of-bed elevation for nocturnal symptoms, and avoidance of specific food triggers (alcohol, coffee, spicy foods) only if the patient identifies these as consistent precipitants 1

Management of Inadequate Response

If symptoms persist or only partially respond after 4-8 weeks of once-daily PPI:

• Escalate to twice-daily PPI dosing (before breakfast and dinner), as expert consensus unanimously supports this approach despite limited trial data, based on pharmacodynamic principles 1

• Verify medication compliance before dose escalation 1

• Consider switching to an alternative PPI if side effects (headache, diarrhea, constipation, abdominal pain) are limiting adherence 1

Evaluation After Failed Empirical Therapy

If symptoms remain troublesome despite twice-daily PPI therapy for 4-8 weeks, this represents treatment failure and warrants further diagnostic evaluation 1:

Step 1: Esophageal Manometry

• Perform manometry to localize the lower esophageal sphincter for potential pH monitoring, evaluate peristaltic function, and diagnose subtle presentations of major motor disorders (achalasia, distal esophageal spasm) 1

• High-resolution manometry has superior sensitivity to conventional manometry for recognizing atypical cases 1

Step 2: Ambulatory pH or Impedance-pH Monitoring

• Conduct ambulatory reflux monitoring OFF PPI therapy (withheld for 7 days) if manometry shows no major abnormality 1

• Wireless pH monitoring is superior to catheter studies due to extended 48-hour recording and better accuracy 1

• Interpretation of results 1:

  • AET <4.0% on all days with normal endoscopy = No GERD: Consider functional heartburn or other functional esophageal disorder
  • AET ≥6.0% on ≥2 days = Conclusive GERD: Optimize PPI therapy or consider anti-reflux surgery
  • AET ≥4.0% but not meeting GERD criteria = Borderline GERD: Optimize PPI, aggressive lifestyle modifications, consider neuromodulators

Important Clinical Pitfalls

• Do not add nocturnal H2-receptor antagonists to twice-daily PPI therapy, as there is no evidence of improved efficacy 1

• Do not use metoclopramide as monotherapy or adjunctive therapy, as it is ineffective and carries risk of adverse effects (Grade D recommendation) 1

• Avoid performing pH monitoring while on PPI therapy for initial diagnostic evaluation, as normative data interpretation is unclear and rarely changes management 1

• Recognize that up to 75% of patients with typical reflux symptoms have normal endoscopy (NERD), and this does not exclude GERD as the diagnosis 2

Alternative Diagnoses to Consider

If extensive evaluation reveals no pathologic GERD:

• Functional heartburn: Normal acid exposure with symptoms not temporally associated with reflux events 1

• Reflux hypersensitivity: Normal acid exposure but symptoms correlate with physiologic reflux episodes 1

• Eosinophilic esophagitis: Obtain at least 5 esophageal biopsies even with normal-appearing mucosa if dysphagia is present 1

• Atypical presentations of achalasia or esophageal spasm: Identified by high-resolution manometry 1

Long-Term Management Considerations

• Most patients with GERD severe enough to warrant initial PPI therapy will require chronic treatment, but many can tolerate dose reduction while maintaining symptom control 1

• On-demand therapy is reasonable for NERD patients where symptom control is the primary objective, as there is no evidence that intermittent symptoms without esophagitis cause harm 1

• The decision for maintenance therapy is driven by symptom impact on quality of life rather than disease control, as there are no data suggesting continuous therapy alters natural history beyond reducing peptic stricture risk 1

• Patients requiring chronic PPI can undergo reflux testing at 1 year to determine appropriateness of lifelong therapy 1